These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 3351840)

  • 61. Inflammatory parameters in rheumatoid arthritis during and after administration of an anti-mitotic agent (Podophyllum lignan derivatives).
    Berglund K; Johansson BG; Laurell AB; Sjöholm A; Sturfelt G
    Scand J Rheumatol; 1978; 7(1):61-3. PubMed ID: 675176
    [No Abstract]   [Full Text] [Related]  

  • 62. Calcium metabolism during rifampicin and isoniazid therapy for tuberculosis.
    Brodie MJ; Hillyard CJ
    J R Soc Med; 1982 Nov; 75(11):919. PubMed ID: 7143346
    [No Abstract]   [Full Text] [Related]  

  • 63. Kinetics of rifampicin and isoniazid administered alone and in combination to normal subjects and patients with liver disease.
    Acocella G; Bonollo L; Garimoldi M; Mainardi M; Tenconi LT; Nicolis FB
    Gut; 1972 Jan; 13(1):47-53. PubMed ID: 5060669
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Serum sulfhydryl levels in rheumatoid patients treated with cyclophosphamide.
    Grimaldi MG
    Scand J Rheumatol; 1980; 9(4):237-40. PubMed ID: 7455636
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Can treatment really influence the radiological progression of rheumatoid arthritis?
    Pullar T; Capell HA
    Br J Rheumatol; 1986 Feb; 25(1):2-5. PubMed ID: 3942843
    [No Abstract]   [Full Text] [Related]  

  • 66. A comparison between clinical and laboratory tests in rheumatoid arthritis.
    Grindulis KA; Calverley M; Constable TJ; Forster PJ; Ahmed ME; McConkey B
    Scand J Rheumatol; 1983; 12(3):285-8. PubMed ID: 6623019
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Limited therapeutic action of rifampicin/isoniazid against Leishmania aethiopica.
    van der Meulen J; Mock B; Fekete E; Sarojini PA
    Lancet; 1981 Jul; 2(8239):197-8. PubMed ID: 6114258
    [No Abstract]   [Full Text] [Related]  

  • 68. Blood levels of rifampicin, desacetylrifampicin and isoniazid during combined therapy.
    Mouton RP; Mattie H; Swart K; Kreukniet J; de Wael J
    J Antimicrob Chemother; 1979 Jul; 5(4):447-54. PubMed ID: 489492
    [No Abstract]   [Full Text] [Related]  

  • 69. Rapid oral desensitisation to prophylactic isoniazid.
    Abadoglu O; Epozturk K; Atayik E
    Allergol Immunopathol (Madr); 2011; 39(5):311-2. PubMed ID: 21489680
    [No Abstract]   [Full Text] [Related]  

  • 70. [Pharmacokinetics and clinical importance of the interactions of rifampicin with phenprocoumone and isoniazide].
    von Oldershausen HF; Musch E; Rudolf G; Gieraths A; Schunter C
    Verh Dtsch Ges Inn Med; 1978; (84):1468-72. PubMed ID: 741993
    [No Abstract]   [Full Text] [Related]  

  • 71. Intermittent hypoxia and isoniazid plus rifampicin affect hepatic ultrastructure in mice.
    Wu RH; Zeng YM; Chen XY
    Chin Med J (Engl); 2011 Dec; 124(23):4034-8. PubMed ID: 22340338
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Therapeutic effect of rifampicin and isoniazid against Leishmania tropica major.
    Livshin R; El-On J; Weinrauch L; Greenblatt CL; Even-Paz Z
    Int J Dermatol; 1983; 22(1):61. PubMed ID: 6832881
    [No Abstract]   [Full Text] [Related]  

  • 73. Erythrocyte sedimentation rate as a parameter for drug evaluation in the MRL/l autoimmune mouse.
    Stim TB; Garrabrant TA; Kimball ES; Persico FJ
    Br J Rheumatol; 1989 Feb; 28(1):82-4. PubMed ID: 2917240
    [No Abstract]   [Full Text] [Related]  

  • 74. [Algodystrophy syndrome].
    Leiber B; Olbrich G
    Monatsschr Kinderheilkd (1902); 1972 Sep; 120(9):398-9. PubMed ID: 5082811
    [No Abstract]   [Full Text] [Related]  

  • 75. [In vitro action of isoniazid on erythrosedimentation rate].
    GUALLAR SEGARRA J
    Rev Clin Esp; 1956 Aug; 62(3):173-5. PubMed ID: 13379841
    [No Abstract]   [Full Text] [Related]  

  • 76. Indications for isoniazid antituberculous prophylaxis in the course of nontuberculous disease.
    OMODEI ZORINI A
    Am Rev Tuberc; 1958 Sep; 78(3):485-7. PubMed ID: 13571607
    [No Abstract]   [Full Text] [Related]  

  • 77. [Problem of anabolic properties of isoniazid].
    BUCHWALD G
    Tuberkulosearzt; 1957 Feb; 11(2):86-92. PubMed ID: 13422649
    [No Abstract]   [Full Text] [Related]  

  • 78. Patterns of T and B cell responses to Mycobacterium tuberculosis membrane-associated antigens and their relationship with disease activity in rheumatoid arthritis patients with latent tuberculosis infection.
    Kumar SK; Arya S; Singh A; Misra R; Aggarwal A; Sinha S
    PLoS One; 2021; 16(8):e0255639. PubMed ID: 34339423
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Randomized, placebo-controlled phase II trial of heat-killed Mycobacterium vaccae (Longcom batch) formulated as an oral pill (V7).
    Efremenko YV; Butov DA; Prihoda ND; Zaitzeva SI; Yurchenko LV; Sokolenko NI; Butova TS; Stepanenko AL; Kutsyna GA; Jirathitikal V; Bourinbaiar AS
    Hum Vaccin Immunother; 2013 Sep; 9(9):1852-6. PubMed ID: 23782489
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Is there a role for antibiotics in the treatment of patients with rheumatoid arthritis?
    O'Dell JR
    Drugs; 1999 Mar; 57(3):279-82. PubMed ID: 10193682
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.